New Zealand markets open in 3 hours 38 minutes

Tonix Pharmaceuticals Holding Corp. (TNXP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.1826+0.0026 (+1.44%)
As of 02:22PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 17.20M
Enterprise value 2.06M
Trailing P/E 0.29
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.39
Price/book (mrq)0.16
Enterprise value/revenue 0.27
Enterprise value/EBITDA 0.94

Trading information

Stock price history

Beta (5Y monthly) 2.17
52-week change 3-90.48%
S&P500 52-week change 326.16%
52-week high 32.1300
52-week low 30.1200
50-day moving average 30.2324
200-day moving average 30.4891

Share statistics

Avg vol (3-month) 32.45M
Avg vol (10-day) 32.02M
Shares outstanding 595.54M
Implied shares outstanding 695.54M
Float 879.88M
% held by insiders 10.01%
% held by institutions 120.71%
Shares short (30 Apr 2024) 41.6M
Short ratio (30 Apr 2024) 40.52
Short % of float (30 Apr 2024) 41.67%
Short % of shares outstanding (30 Apr 2024) 41.67%
Shares short (prior month 28 Mar 2024) 41.25M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 301 Nov 2019
Ex-dividend date 4N/A
Last split factor 216:100
Last split date 310 May 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-723.18%

Management effectiveness

Return on assets (ttm)-38.93%
Return on equity (ttm)-74.61%

Income statement

Revenue (ttm)7.77M
Revenue per share (ttm)0.46
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -114.09M
Net income avi to common (ttm)-116.66M
Diluted EPS (ttm)-6.8500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)24.95M
Total cash per share (mrq)0.29
Total debt (mrq)9.81M
Total debt/equity (mrq)9.30%
Current ratio (mrq)2.53
Book value per share (mrq)1.80

Cash flow statement

Operating cash flow (ttm)-102M
Levered free cash flow (ttm)-82M